Ventria Bioscience
Junction City, KS, US· latest recorded location
Ventria Bioscience is named on 12 US grants and 20 published applications in this corpus. Its most frequent classification is C12N (Microorganisms or enzymes).
- Granted patents
- 12
- Published applications
- 20
- Inventors
- 34
- Granted in 2026 so far
- 0
- Most recent grant
- 20 Apr 2021
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2003 | 0 | 2 |
| 2004 | 1 | 1 |
| 2005 | 0 | 0 |
| 2006 | 2 | 0 |
| 2007 | 1 | 1 |
| 2008 | 1 | 1 |
| 2009 | 1 | 0 |
| 2010 | 1 | 2 |
| 2011 | 0 | 1 |
| 2012 | 1 | 2 |
| 2013 | 1 | 1 |
| 2014 | 1 | 0 |
| 2015 | 0 | 0 |
| 2016 | 1 | 1 |
| 2017 | 0 | 0 |
| 2018 | 0 | 1 |
| 2019 | 0 | 0 |
| 2020 | 0 | 1 |
| 2021 | 1 | 3 |
| 2022 | 0 | 1 |
| 2023 | 0 | 2 |
By publication year.
Technology areas
Share of 32 documents
- C12NMicroorganisms or enzymes28
- C07KPeptides26
- A23LFoods, foodstuffs or non-alcoholic beverages, not otherwise provided for16
- A23KFodder14
- A23VIndexing scheme relating to foods, foodstuffs or non-alcoholic beverages and lactic or14
- B82YSpecific uses or applications of nanostructures13
- G01NInvestigating or analysing materials by determining their chemical or physical properties13
- A61PTherapeutic uses of medicines11
- A61KMedicines and medical preparations8
- C12PFermentation or enzyme-using processes to synthesise a desired chemical compound or composition2
Recent patents
- Cell culture media containing combinations of proteins20 Apr 2021US 10,981,974 B2
- Non-glycosylated transferrin expressed in monocots26 Apr 2016US 9,321,828 B2
- Monocot seed product comprising a human blood protein1 Apr 2014US 8,686,225 B2
- Methods and compositions comprising heat shock proteins17 Dec 2013US 8,609,416 B2
- Monocot seed product comprising a human serum albumin protein17 Apr 2012US 8,158,857 B2
- Enhanced expression yield of immunoglobulin a in eukaryotes27 Apr 2023US 2023/0126423 A1
- Lactoferrin compositions and methods for modulation of t cell subtypes and treatment of autoimmune diseases9 Mar 2023US 2023/0073594 A1
- Cell culture media containing combinations of proteins20 Oct 2022US 2022/0332794 A1
- Formulations of immunoglobulin a14 Oct 2021US 2021/0317189 A1
- Cell culture media containing combinations of proteins22 Jul 2021US 2021/0221870 A1
Most cited
By later US patents
- Expression of human serum albumin (HSA) in monocot seeds27US 7,304,208 B22007
- Expression of human milk proteins in transgenic plants26US 7,417,178 B22008
- Expression of human milk proteins in transgenic plants21US 6,991,824 B22006
- Method of making an anti-infective composition for treating oral infections20US 7,138,150 B22006
- Expression of human milk proteins in transgenic plants19US 7,718,851 B22010